Table 1 a and b: Characteristics of general practice clinics and patients not receiving oral anticoagulant treatment
a: Clinics | Audit (n = 12) | Reference (n = 325) | P-value* |
List size - n (%) | |||
<2,000 patients | 2 (16.7) | 96 (29.6) | 0.399 |
2–4,000 patients | 3 (25.0) | 101 (31.1) | |
>4,000 patients | 7 (58.3) | 128 (39.4) | |
GPs in clinic - n (%) | |||
1 | 2 (16.7) | 98 (30.2) | 0.544 |
2 | 3 (25.0) | 83 (25.6) | |
≥3 | 7 (58.3) | 144 (44.3) | |
GP age (years) Mean (sd) | 48.8 (7.7) | 50.0 (10.3) | 0.472 |
GP sex– n (%) | |||
Female | 23 (59.0) | 479 (59.2) | 0.977 |
Number of patients per GP Mean (sd) | 1,587 (197) | 1,582 (322) | 0.962 |
Number of AF patients per GP Mean (sd) | 51.4 (25.5) | 48.8 (24.0) | 0.708 |
AF patients– n (%) OAC treatment | 1,208 (86.1) | 25,774 (86.6) | 0.596 |
No OAC treatment | 195 (13.9) | 3,990 (13.4) | |
b: Patients | Audit (n = 195) | Reference (n = 3, 990) | P-value* |
Age (years) Mean (sd) | 64.5 (15.4) | 64.2 (15.0) | 0.802 |
Sex– n (%) Female | 66 (33.9) | 1,339 (33.6) | 0.934 |
Time since AF diagnosis (years) | |||
Mean (sd) | 5.9 (3.9) | 5.5 (4.0) | 0.224 |
CHA₂DS₂-VASc score**– n (%) | |||
0 | 86 (44.1) | 1,753 (43.9) | 0.735 |
1 | 28 (14.4) | 668 (16.7) | |
≥2 | 70 (35.9) | 1,315 (33.0) | |
Unspecified | 11 (5.6) | 254 (6.4) | |
HAS-BLED score**– n (%) | |||
0 | 63 (32.3) | 1,237 (31.0) | 0.684 |
1 | 45 (23.1) | 1,057 (26.5) | |
≥2 | 76 (39.0) | 1,442 (36.1) | |
Unspecified | 11 (5.6) | 254 (6.4) | |
Charlson Comorbidity Index**– n (%) | |||
0 | 110 (56.4) | 2,413 (60.5) | 0.651 |
1–2 | 59 (30.3) | 1,129 (28.3) | |
3–4 | 18 (9.2) | 295 (7.4) | |
≥5 | 8 (4.1) | 153 (3.8) | |